Quick Answer
SkinHealth Systems Inc. reported Operating Income Loss of -$20.80 million for the year ending 2025.
- SkinHealth Systems Inc. showed an increase of +69.3% in Operating Income Loss from 2024 to 2025.
- This data is from SkinHealth Systems Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: -$7.92 million | Q3 2020: $2.79 million | Q1 2021: $2.38 million | Q2 2021: -$26.35 million | Q3 2021: -$5.46 million | Q1 2022: -$14.01 million | Q2 2022: -$5.03 million | Q3 2022: -$4.35 million | Q1 2023: -$17.31 million | Q2 2023: -$13.15 million | Q3 2023: -$82.10 million | Q1 2024: -$16.99 million | Q2 2024: -$22.11 million | Q3 2024: -$21.52 million | Q1 2025: -$12.02 million | Q2 2025: -$2.70 million | Q3 2025: -$6.24 million.
- Over the full 7 years of available data (2019 to 2025), SkinHealth Systems Inc.'s Operating Income Loss has declined by 254.5%.
- Historical annual values: Fiscal year 2025: -$20.80 million | Fiscal year 2024: -$67.77 million | Fiscal year 2023: -$130.92 million | Fiscal year 2022: -$25.84 million | Fiscal year 2021: -$39.93 million | Fiscal year 2020: -$17.18 million | Fiscal year 2019: $13.46 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: